Skip to content

Clinical trials

Terminated Phase 3 Muscular Dystrophy, Duchenne trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Status: Terminated Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20111
20132
20141
20161
20182
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kyntra Bio2
PTC Therapeutics2
Santhera Pharmaceuticals2
Assistance Publique - Hôpitaux de Paris1
BioMarin Pharmaceutical1
Catabasis Pharmaceuticals1
Cooperative International Neuromuscular Research Group1
Eli Lilly and Company1
GlaxoSmithKline1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne14
Muscular Dystrophies6
Neuromuscular Diseases4
Musculoskeletal Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Nervous System Diseases2
Amyotrophic Lateral Sclerosis1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.